Bausch & Lomb Will Conduct ZyLET Phase IV Study In 60 Young Children
This article was originally published in The Pink Sheet Daily
Executive Summary
Pediatric study is B&L’s only postmarketing commitment for the combination ophthalmic, FDA’s approval letter states. The company is expected to launch ZyLET in the first quarter of 2005.